Phosphatidylinositol 3-kinase (PI3K), a heterodimeric enzyme composed of a regulatory subunit (p85α/β, p55α/γ, p50α) and a catalytic subunit (p110α/β), is an essential component of the canonical insulin signaling cascade in adipose tissue. Insulin-stimulated PI3K activity is decreased in obese adipose tissue in parallel with a 4-fold increase in p55α abundance; heterozygous deletion of Pik3r1 limits regulatory subunit expression and enhances adipocyte insulin signaling. Additionally, genetic deletion of p55α/p50α in mice has been shown to increase adipocyte glucose uptake and systemic insulin sensitivity. Therefore, we hypothesized that adipocyte-specific p55α overexpression (OX) would reduce adipocyte insulin signaling and decrease systemic glucose tolerance. To test this hypothesis, we generated mice with p55α knock-in at the endogenous ROSA26 locus. The recombination cassette was made by flanking the p55α cDNA and a floxed 4x SV40 polyA STOP signal with FRT and F3. The insertion of Pik3r1 at the ROSA26 locus mediated by Flp-recombinase in ES cells targeted with FRT-PGK-neo-F3 at the ROSA26 locus. The polyA STOP signal was removed by crossing the p55α flox (Fl/Fl) mice with mice carrying Adipoq-cre recombinase (OX). At 12 weeks of age, the metabolic phenotype, glucose tolerance and adipocyte insulin signaling were measured in Fl/FL and OX mice. In adipose tissue, p55α abundance was 7-fold higher in OX compared to FL/FL controls with no difference detected in p85α abundance. Body weight and adiposity was not different between FL/FL and OX mice. Food intake, energy expenditure and the respiratory quotient were not different in OX vs. FL/FL, despite a decrease in total activity in OX mice. Contrary to our hypothesis, glucose AUC calculated from oral glucose tolerance tests was 40% lower (P=0.005) in OX vs. FL/FL. Overall these data suggest that increased expression of the p55α regulatorysubunit, in contrast to p85α, enhances PI3K activity and insulin signaling in adipocytes.

Disclosure

Z.S. Clayton: None. C. McCurdy: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.